Organoid electrophysiology is providing pharmaceutical and biotech companies with human-relevant models for testing drug efficacy, modeling diseases, and reducing reliance on animal studies, ultimately accelerating the development of safer and more effective therapeutics.
Organoid technology is poised to revolutionize the development of brain-controlled prosthetics. By bridging the gap between the body’s central nervous system and a synthetic device, research with neural organoids could lead to the development of prosthetics capable of real-time interaction with the human brain through closed-loop feedback systems. Multielectrode array technology (also called “microelectrode array” or “MEA”) from Multi Channel Systems is ideally suited for studying this complex interaction and developing innovations in prosthetic research.
Need a pump? We'll help you choose. Download our free Pump Selection Guide to help you choose the right pump for your application and budget.
PTSD affects millions, with varied trauma responses complicating treatment. Advanced research tools, including telemetry and behavioral systems, help uncover physiological and behavioral insights, paving the way for personalized therapies. Studies highlight sex-specific stress adaptations, novel drug targets, and physiological biomarkers, advancing understanding and treatment options for this complex disorder. Continued innovation is key to improving PTSD care.
Unlike traditional MEA recordings that can only measure field potentials, the IntraCell uses a laser to precisely optoporate cardiomyocytes underneath each electrode.
Lung fibrosis is a serious condition that limits lung function, and traditional research methods often rely on invasive techniques. However, Whole Body Plethysmography (WBP) offers a noninvasive solution for tracking fibrosis progression over time. This method allows researchers to monitor lung function in animal models without terminal procedures, providing valuable insights for developing effective treatments and understanding disease development.
Unlock the future of Alzheimer’s research with groundbreaking lab tools from Harvard Bioscience. This video showcases how our cutting-edge technologies, including BTX's electroporation systems, Biochrom's molecular analysis tools, and advanced electrophysiology solutions, accelerate discoveries in Alzheimer’s disease. From gene therapy to live cell imaging and cognitive testing in animal models, watch how Harvard Bioscience is building labs to advance Alzheimer’s research and equip the next generation of scientists with tools that could lead to life-changing breakthroughs.
According to a recent study published by The Lancet Neurology with contributions from the World Health Organization (WHO), neurological conditions such as, dementia, epilepsy, stroke, and migraine affect more than three billion people worldwide, making these conditions the leading cause of illness and disability globally. Despite advances in neuroscience research, many of these conditions do not have fully effective treatments, making the development of innovative therapies a pressing need.
Microelectrode arrays – also known as “multielectrode arrays” or MEAs – are powerful tools used in neuroscience, cardiac research, and pharmacology to study the electrical activity of excitable tissues like neurons and cardiac cells. But what exactly is an MEA system, and how do they work?
Harvard Bioscience is gearing up to showcase its latest innovations at the Society for Neuroscience (SfN) 2024 meeting, happening from October 5-9 in Chicago, IL.
